$NARI
Inari Medical Inc

2023 Q1 Form 10-K Financial Statement

#000095017023004675 Filed on February 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $116.2M $107.8M $383.5M
YoY Change 33.91% 29.5% 38.45%
Cost Of Revenue $13.74M $13.13M $44.51M
YoY Change 37.86% 58.55% 79.77%
Gross Profit $102.4M $94.64M $339.0M
YoY Change 33.39% 26.3% 34.39%
Gross Profit Margin 88.17% 87.82% 88.39%
Selling, General & Admin $85.70M $79.12M $292.8M
YoY Change 34.47% 47.38% 53.83%
% of Gross Profit 83.67% 83.59% 86.39%
Research & Development $22.06M $20.41M $74.22M
YoY Change 36.75% 9.0% 45.48%
% of Gross Profit 21.54% 21.57% 21.9%
Depreciation & Amortization $1.348M $1.243M $4.673M
YoY Change 26.81% 34.23% 54.02%
% of Gross Profit 1.32% 1.31% 1.38%
Operating Expenses $107.8M $100.5M $367.1M
YoY Change 34.93% 37.36% 52.07%
Operating Profit -$5.338M -$5.891M -$28.10M
YoY Change 73.2% -437.4% -359.12%
Interest Expense $40.00K $896.0K $294.0K
YoY Change -45.21% -1856.86% -0.34%
% of Operating Profit
Other Income/Expense, Net $4.144M $187.0K $1.914M
YoY Change -8917.02% -1435.71% -1303.77%
Pretax Income -$1.194M -$4.808M -$26.19M
YoY Change -61.84% -386.02% -345.06%
Income Tax $1.024M $990.0K $3.082M
% Of Pretax Income
Net Earnings -$2.218M -$5.798M -$29.27M
YoY Change -29.11% -623.76% -397.43%
Net Earnings / Revenue -1.91% -5.38% -7.63%
Basic Earnings Per Share -$0.04 -$0.55
Diluted Earnings Per Share -$0.04 -$0.11 -$0.55
COMMON SHARES
Basic Shares Outstanding 54.31M 53.65M 52.84M
Diluted Shares Outstanding 54.76M shares 52.84M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $328.4M $326.4M $326.4M
YoY Change -3.03% 85.35% 85.35%
Cash & Equivalents $56.56M $60.22M $60.22M
Short-Term Investments $271.9M $266.2M $266.2M
Other Short-Term Assets $4.942M $5.312M $5.312M
YoY Change -15.51% -6.71% -6.71%
Inventory $36.50M $32.58M $32.58M
Prepaid Expenses
Receivables $55.72M $58.61M $58.61M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $425.6M $422.9M $422.9M
YoY Change 2.97% 72.47% 72.47%
LONG-TERM ASSETS
Property, Plant & Equipment $21.25M $21.66M $72.36M
YoY Change 17.03% 31.47% 17.89%
Goodwill $0.00
YoY Change
Intangibles $0.00 $0.00
YoY Change
Long-Term Investments $8.600M $0.00 $8.300M
YoY Change -100.0% 108.39%
Other Assets $9.084M $8.889M $589.0K
YoY Change 46.14% 806.12% -39.96%
Total Long-Term Assets $80.93M $81.25M $81.25M
YoY Change 14.35% 22.46% 22.46%
TOTAL ASSETS
Total Short-Term Assets $425.6M $422.9M $422.9M
Total Long-Term Assets $80.93M $81.25M $81.25M
Total Assets $506.5M $504.2M $504.2M
YoY Change 4.63% 61.82% 61.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.352M $7.659M $7.659M
YoY Change 21.2% 17.09% 17.09%
Accrued Expenses $40.99M $48.52M $48.52M
YoY Change 38.88% 34.87% 34.87%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $48.34M $56.17M $56.17M
YoY Change 35.86% 32.13% 32.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $31.46M $0.00 $30.98M
YoY Change 2121.61% -100.0% 3.88%
Total Long-Term Liabilities $31.46M $0.00 $30.98M
YoY Change 2121.61% -100.0% 3.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $48.34M $56.17M $56.17M
Total Long-Term Liabilities $31.46M $0.00 $30.98M
Total Liabilities $79.80M $87.15M $87.15M
YoY Change 22.21% 20.48% 20.48%
SHAREHOLDERS EQUITY
Retained Earnings -$49.07M -$46.85M
YoY Change 136.91% 166.45%
Common Stock $475.8M $463.0M
YoY Change 8.07% 80.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $426.7M $417.0M $417.0M
YoY Change
Total Liabilities & Shareholders Equity $506.5M $504.2M $504.2M
YoY Change 4.63% 61.82% 61.82%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$2.218M -$5.798M -$29.27M
YoY Change -29.11% -623.76% -397.43%
Depreciation, Depletion And Amortization $1.348M $1.243M $4.673M
YoY Change 26.81% 34.23% 54.02%
Cash From Operating Activities -$2.013M $11.26M -$13.97M
YoY Change -77.88% -25.0% -154.82%
INVESTING ACTIVITIES
Capital Expenditures $964.0K $1.778M $9.951M
YoY Change -64.88% -165.42% -27.07%
Acquisitions $0.00
YoY Change
Other Investing Activities -$3.079M -$31.47M -$185.3M
YoY Change -95.65% -51688.52% 395.67%
Cash From Investing Activities -$4.043M -$33.25M -$195.2M
YoY Change -94.5% 1151.3% 282.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.466M -1.689M 177.1M
YoY Change -98.6% 172.42% 4249.08%
NET CHANGE
Cash From Operating Activities -$2.013M 11.26M -13.97M
Cash From Investing Activities -$4.043M -33.25M -195.2M
Cash From Financing Activities $2.466M -1.689M 177.1M
Net Change In Cash -$3.660M -23.68M -32.53M
YoY Change -103.9% -301.88% 48.78%
FREE CASH FLOW
Cash From Operating Activities -$2.013M $11.26M -$13.97M
Capital Expenditures $964.0K $1.778M $9.951M
Free Cash Flow -$2.977M $9.477M -$23.92M
YoY Change -74.87% -46.53% -302.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 us-gaap Defined Contribution Plan Tax Status Extensible List
DefinedContributionPlanTaxStatusExtensibleList
http://fasb.org/us-gaap/2022#QualifiedPlanMember
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001531048
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2902923
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
6001 Oak Canyon
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39293
CY2022 dei Entity Registrant Name
EntityRegistrantName
Inari Medical, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q4 nari Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
8889000
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
CY2022 dei City Area Code
CityAreaCode
877
CY2022 dei Local Phone Number
LocalPhoneNumber
923-4747
CY2022 dei Security12b Title
Security12bTitle
Common stock, $0.001 par value per share
CY2022 dei Trading Symbol
TradingSymbol
NARI
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
3280000000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54313676
CY2022 dei Auditor Firm
AuditorFirmId
243
CY2022 dei Auditor Name
AuditorName
BDO USA, LLP
CY2022 dei Auditor Location
AuditorLocation
Costa Mesa, California
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60222000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
92752000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
266179000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
83348000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
58611000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42351000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32581000
CY2021Q4 us-gaap Inventory Net
InventoryNet
21053000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5312000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5694000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
422905000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
245198000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21655000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16471000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
50703000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44909000
CY2021Q4 nari Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
981000
CY2022Q4 us-gaap Long Term Investments
LongTermInvestments
0
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
3983000
CY2022Q4 us-gaap Assets
Assets
504152000
CY2021Q4 us-gaap Assets
Assets
311542000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7659000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6541000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38955000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24433000
CY2022Q4 nari Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
8249000
CY2021Q4 nari Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
10737000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1311000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
802000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56174000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
42513000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30976000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28404000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1416000
CY2022Q4 us-gaap Liabilities
Liabilities
87150000
CY2021Q4 us-gaap Liabilities
Liabilities
72333000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54021656
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54021656
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50313452
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50313452
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
54000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
50000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
462949000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
257144000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
849000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-402000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46850000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17583000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
417002000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239209000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
504152000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311542000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
383471000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
276984000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139670000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
44506000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
24757000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13106000
CY2022 us-gaap Gross Profit
GrossProfit
338965000
CY2021 us-gaap Gross Profit
GrossProfit
252227000
CY2020 us-gaap Gross Profit
GrossProfit
126564000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
74221000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51018000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18399000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
292843000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
190365000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89746000
CY2022 us-gaap Operating Expenses
OperatingExpenses
367064000
CY2021 us-gaap Operating Expenses
OperatingExpenses
241383000
CY2020 us-gaap Operating Expenses
OperatingExpenses
108145000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-28099000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
10844000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
18419000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
1852000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
154000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
484000
CY2022 us-gaap Interest Expense
InterestExpense
294000
CY2021 us-gaap Interest Expense
InterestExpense
295000
CY2020 us-gaap Interest Expense
InterestExpense
1135000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3317000
CY2022 nari Other Income Expense
OtherIncomeExpense
356000
CY2021 nari Other Income Expense
OtherIncomeExpense
-18000
CY2020 nari Other Income Expense
OtherIncomeExpense
-662000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1914000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-159000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4630000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26185000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10685000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13789000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3082000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
845000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-29267000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
9840000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
13789000
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-592000
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-379000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1843000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-27000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
4000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1251000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-406000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28016000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9434000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13793000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52837674
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49815914
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32033827
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52837674
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55594159
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51554996
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-39144000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
54170000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
16300000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
162979000
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
4486000
CY2020 nari Exercise Of Common Stock Warrants
ExerciseOfCommonStockWarrants
5000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
466000
CY2020 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-25000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3524000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
13789000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
200254000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
869000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
5558000
CY2021 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-2354000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25448000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-406000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
9840000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
239209000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
810000
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
8422000
CY2022 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-6489000
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
11900000
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
174395000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28671000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1251000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-29267000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25486000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
417002000
CY2022 us-gaap Profit Loss
ProfitLoss
-29267000
CY2021 us-gaap Profit Loss
ProfitLoss
9840000
CY2020 us-gaap Profit Loss
ProfitLoss
13789000
CY2022 us-gaap Depreciation
Depreciation
4673000
CY2021 us-gaap Depreciation
Depreciation
3034000
CY2020 us-gaap Depreciation
Depreciation
1385000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
143000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
143000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
181000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2446000
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1274000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
28671000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
25448000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
3524000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
736000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-22000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2022 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-94000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-69000
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-237000
CY2022 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-648000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3317000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
17030000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14361000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16706000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11688000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10488000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6644000
CY2022 nari Increase Decrease In Prepaid Expenses Deposits And Other Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssets
-580000
CY2021 nari Increase Decrease In Prepaid Expenses Deposits And Other Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssets
3430000
CY2020 nari Increase Decrease In Prepaid Expenses Deposits And Other Assets
IncreaseDecreaseInPrepaidExpensesDepositsAndOtherAssets
2458000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1140000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3514000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
498000
CY2022 nari Increase Decrease In Payroll Related Accruals Accrued Expenses And Other Liabilities
IncreaseDecreaseInPayrollRelatedAccrualsAccruedExpensesAndOtherLiabilities
10691000
CY2021 nari Increase Decrease In Payroll Related Accruals Accrued Expenses And Other Liabilities
IncreaseDecreaseInPayrollRelatedAccrualsAccruedExpensesAndOtherLiabilities
25992000
CY2020 nari Increase Decrease In Payroll Related Accruals Accrued Expenses And Other Liabilities
IncreaseDecreaseInPayrollRelatedAccrualsAccruedExpensesAndOtherLiabilities
4141000
CY2022 nari Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-923000
CY2021 nari Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-772000
CY2020 nari Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
0
CY2021 nari Lease Prepayments For Lessors Owned Leasehold Improvements
LeasePrepaymentsForLessorsOwnedLeaseholdImprovements
-14755000
CY2020 nari Lease Prepayments For Lessors Owned Leasehold Improvements
LeasePrepaymentsForLessorsOwnedLeaseholdImprovements
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13972000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1912000
CY2022 nari Lease Prepayments For Lessors Owned Leasehold Improvements
LeasePrepaymentsForLessorsOwnedLeaseholdImprovements
-4238000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9951000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13645000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5460000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
489605000
CY2021 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
134377000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
49977000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
312600000
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
97000000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2022 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
8260000
CY2021 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0
CY2020 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-195216000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51022000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-55437000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
174395000
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
164361000
CY2022 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
8422000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
5558000
CY2020 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
0
CY2022 nari Proceeds From Exercise Of Stock Option And Warrants
ProceedsFromExerciseOfStockOptionAndWarrants
810000
CY2021 nari Proceeds From Exercise Of Stock Option And Warrants
ProceedsFromExerciseOfStockOptionAndWarrants
869000
CY2020 nari Proceeds From Exercise Of Stock Option And Warrants
ProceedsFromExerciseOfStockOptionAndWarrants
471000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6489000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2354000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
25000
CY2022 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2021 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
30250000
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
442000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
177138000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4073000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
144115000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-480000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-402000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-32530000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21865000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
90590000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92752000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114617000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24027000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60222000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
92752000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
114617000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3417000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
472000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
154000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
151000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
151000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
999000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
3947000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
28648000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0
CY2022 nari Common Stock Issued On Conversion Of Convertible Preferred Stock
CommonStockIssuedOnConversionOfConvertiblePreferredStock
0
CY2021 nari Common Stock Issued On Conversion Of Convertible Preferred Stock
CommonStockIssuedOnConversionOfConvertiblePreferredStock
0
CY2020 nari Common Stock Issued On Conversion Of Convertible Preferred Stock
CommonStockIssuedOnConversionOfConvertiblePreferredStock
54170000
CY2022 nari Common Stock Warrants Issued On Conversion Of Preferred Stock Warrants And The Reclassification Of The Warrant Liability
CommonStockWarrantsIssuedOnConversionOfPreferredStockWarrantsAndTheReclassificationOfTheWarrantLiability
0
CY2021 nari Common Stock Warrants Issued On Conversion Of Preferred Stock Warrants And The Reclassification Of The Warrant Liability
CommonStockWarrantsIssuedOnConversionOfPreferredStockWarrantsAndTheReclassificationOfTheWarrantLiability
0
CY2020 nari Common Stock Warrants Issued On Conversion Of Preferred Stock Warrants And The Reclassification Of The Warrant Liability
CommonStockWarrantsIssuedOnConversionOfPreferredStockWarrantsAndTheReclassificationOfTheWarrantLiability
4486000
CY2022 nari Deferred Initial Public Offering Cost Recorded To Additional Paid In Capital
DeferredInitialPublicOfferingCostRecordedToAdditionalPaidInCapital
0
CY2021 nari Deferred Initial Public Offering Cost Recorded To Additional Paid In Capital
DeferredInitialPublicOfferingCostRecordedToAdditionalPaidInCapital
0
CY2020 nari Deferred Initial Public Offering Cost Recorded To Additional Paid In Capital
DeferredInitialPublicOfferingCostRecordedToAdditionalPaidInCapital
1382000
CY2022Q4 us-gaap Other Investments
OtherInvestments
8300000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;font-style:italic;min-width:fit-content;">Management Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements may include, but are not limited to, collectability of receivables, recoverability of long-lived assets, valuation of inventory, operating lease right-of-use ("ROU") assets and liabilities, other investments, fair value of stock options, fair value of common stock warrants, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Arial&quot;, sans-serif;min-width:fit-content;">recoverability of net deferred tax assets and related valuation allowance, and certain accruals. Estimates are based on historical experience and on various assumptions that the Company believes are reasonable under current circumstances. Actual results could differ materially from those estimates. Management periodically evaluates such estimates and assumptions, and they are adjusted prospectively based upon such periodic evaluation.</span></p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
776000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
40000
CY2022 us-gaap Revenues
Revenues
383471000
CY2021 us-gaap Revenues
Revenues
276984000
CY2020 us-gaap Revenues
Revenues
139670000
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
631000
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
194000
CY2020 us-gaap Product Warranty Expense
ProductWarrantyExpense
0
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1200000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1300000
CY2022Q4 nari Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2022Q4 nari Fair Value Assets Level2 To Level1 Transfers Amount2
FairValueAssetsLevel2ToLevel1TransfersAmount2
0
CY2022Q4 nari Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2022Q4 nari Fair Value Liabilities Level2 To Level1 Transfers Amount2
FairValueLiabilitiesLevel2ToLevel1TransfersAmount2
0
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
284688000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1871000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
51000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
286508000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
135949000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
14000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
37000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
135926000
CY2021 nari Prepaid Operatingleasepayments
PrepaidOperatingleasepayments
4200000
CY2022Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P17Y1M6D
CY2021Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P19Y2M12D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
13943000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5763000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3396000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1490000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15242000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
13800000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32581000
CY2021Q4 us-gaap Inventory Net
InventoryNet
21053000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
30483000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21252000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8828000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4781000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21655000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
16471000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
1047000
CY2022 us-gaap Capitalized Contract Cost Amortization Method
CapitalizedContractCostAmortizationMethod
The capitalized costs are amortized on a straight-line basis over the non-cancelable contract terms
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
137000000
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
391000000
CY2020Q4 nari Operating Leases Number Of Lease Period Extension Options
OperatingLeasesNumberOfLeasePeriodExtensionOptions
2
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42200000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
28600000
CY2020Q4 nari Tenant Allowance
TenantAllowance
13500000
CY2020Q4 nari Tenant Allowance Related To Prepaid Lease Payments
TenantAllowanceRelatedToPrepaidLeasePayments
3700000
CY2022 nari Prepaid Operatingleasepayments
PrepaidOperatingleasepayments
2800000
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
CY2021 nari Income Tax Reconciliation Stock Warrants
IncomeTaxReconciliationStockWarrants
0
CY2020 nari Income Tax Reconciliation Stock Warrants
IncomeTaxReconciliationStockWarrants
696000
CY2022 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2700000
CY2021 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
14600000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
4276000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1568000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
240000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
622000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
473000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
790000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3237000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3333000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2812000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2683000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2741000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
38504000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
53310000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21023000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
32287000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1311000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30976000
CY2021Q4 nari Research And Development Expense Accrued
ResearchAndDevelopmentExpenseAccrued
2800000
CY2022Q4 nari Research And Development Expense Accrued
ResearchAndDevelopmentExpenseAccrued
1300000
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
116000
CY2021 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
116000
CY2020 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
95000
CY2022Q4 nari Number Of Letter Of Credit
NumberOfLetterOfCredit
3
CY2020Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
31968570
CY2020Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
31968570
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
174400000
CY2022Q1 nari Underwriters Discounts And Commissions Expenses
UnderwritersDiscountsAndCommissionsExpenses
11200000
CY2022Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
700000
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
256588
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
256588
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3300000
CY2020Q2 nari Class Of Warrant Exercised For Cash
ClassOfWarrantExercisedForCash
77030
CY2020Q2 nari Number Of Common Stock Shares Issued Upon Exercise Of Preferred Stock Warrants
NumberOfCommonStockSharesIssuedUponExerciseOfPreferredStockWarrants
74723
CY2020Q4 nari Class Of Warrant Exercised For Cash
ClassOfWarrantExercisedForCash
179558
CY2020Q4 nari Number Of Common Stock Shares Issued Upon Exercise Of Preferred Stock Warrants
NumberOfCommonStockSharesIssuedUponExerciseOfPreferredStockWarrants
174776
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2022 us-gaap Dividends
Dividends
0
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28671000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
25448000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3524000
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
66000000.0
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M18D
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7600000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
10300000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4900000
CY2022 nari State Tax Expense Benefit Before Provision
StateTaxExpenseBenefitBeforeProvision
-15787000
CY2021 nari State Tax Expense Benefit Before Provision
StateTaxExpenseBenefitBeforeProvision
18301000
CY2020 nari State Tax Expense Benefit Before Provision
StateTaxExpenseBenefitBeforeProvision
14541000
CY2022 nari Foreign Expense Tax Benefit
ForeignExpenseTaxBenefit
-10398000
CY2021 nari Foreign Expense Tax Benefit
ForeignExpenseTaxBenefit
-7616000
CY2020 nari Foreign Expense Tax Benefit
ForeignExpenseTaxBenefit
-752000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26185000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10685000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13789000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
826000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1997000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
832000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
259000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
13000
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
3082000
CY2021 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
845000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3082000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
845000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.118
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.079
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
14250000
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
0
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10298000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
7750000
CY2022Q4 nari Deferred Tax Assets Operating Lease
DeferredTaxAssetsOperatingLease
7587000
CY2021Q4 nari Deferred Tax Assets Operating Lease
DeferredTaxAssetsOperatingLease
7432000
CY2022Q4 nari Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards
6038000
CY2021Q4 nari Deferred Tax Assets Net Operating Loss And Capital Loss Carryforwards
DeferredTaxAssetsNetOperatingLossAndCapitalLossCarryforwards
8918000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2307000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1511000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2008000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2390000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1321000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3082000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1028000
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1207000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
778000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
44000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
45016000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29851000
CY2022Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
10390000
CY2021Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
9138000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3980000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2810000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
325000
CY2021Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
7000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
14695000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
11955000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30321000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17896000
CY2022Q4 nari Net Deferred Tax Losses And Tax Credit Carryforwards
NetDeferredTaxLossesAndTaxCreditCarryforwards
0
CY2021Q4 nari Net Deferred Tax Losses And Tax Credit Carryforwards
NetDeferredTaxLossesAndTaxCreditCarryforwards
0
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
12400000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5499000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2244000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2896000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-1060000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-317000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
0
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1982000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1181000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
0
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
37000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
14000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
213000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-9351000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-8387000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-3576000
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
8242000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
4162000
CY2020 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
197000
CY2022 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
105000
CY2021 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-1127000
CY2020 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
258000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
103000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
104000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
827000
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
4709000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
845000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3761000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
1621000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12891000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6031000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
110000
CY2022 nari Intercompany Profit In Inventory
IntercompanyProfitInInventory
341000
CY2021 nari Intercompany Profit In Inventory
IntercompanyProfitInInventory
701000
CY2020 nari Intercompany Profit In Inventory
IntercompanyProfitInInventory
0
CY2022 nari Income Tax Reconciliation Stock Warrants
IncomeTaxReconciliationStockWarrants
0
CY2022 nari Operating Loss Carryforward Description
OperatingLossCarryforwardDescription
As a result of losses incurred in the past, the Company has net operating loss ("NOL") carry-forwards that are available to offset future taxable income and subject to expiration rules and to Internal Revenue Code of 1986, as amended (“IRC”) §382. In general, IRC §382 may impact the amount of NOLs that can be utilized each year after certain ownership changes occur. An ownership change occurs, generally, if the percentage of stock of the loss corporation owned by one or more 5% shareholders has increased by more than 50 percentage points relative to the lowest percentage of stock of the loss corporation owned by the same 5% shareholders at any time during the testing period, which is, generally, the three-year period preceding a testing date.
CY2022 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Pursuant to an IRC §382 limitation analysis performed by the Company, it was noted that an ownership change, as defined under IRC §382, occurred on March 29, 2018 and December 31, 2021. Usage of NOL’s generated prior to March 29, 2018 will be limited to $3.0 million for calendar years 2019 through 2022, $0.7 million for 2023, $0.6 million from 2024 through 2039, and $0.2 million for 2040 for both federal and state purposes. The IRC §382 ownership change that occurred on December 31, 2021 did not further limit the use of the Company's NOL's generated prior to December 31, 2021. Of the federal net operating loss and the state net operating loss carryforward amounts, $10.5 million and $19.7 million are subject to the IRC §382 limitation, respectively.
CY2022 us-gaap Tax Credit Carryforward Limitations On Use
TaxCreditCarryforwardLimitationsOnUse
In the ordinary course of its business the Company incurs costs that, for tax purposes, are determined to be qualified research expenditures within the meaning of IRC §41 and are, therefore, eligible for the Increasing Research Activities credit under IRC §41. R&D credit carryovers generated prior to March 29, 2018 are limited under IRC §383 to $0.3 million a year for both federal and state purposes. The Company has adjusted the deferred tax assets related to Federal R&D credit carryover to account for any tax credits that will expire unused due to the IRC §383 limitations.
CY2022Q4 nari Tax Credit Carryforward Limitations On Usage
TaxCreditCarryforwardLimitationsOnUsage
300000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5500000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2700000
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
5500000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
2700000
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2679000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
882000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1091000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2348000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1352000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
287000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
499000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
445000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
0
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
496000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5526000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2679000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
882000
CY2022 us-gaap Significant Change In Unrecognized Tax Benefits Nature Of Event
SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent
It is not expected that there will be a significant change in uncertain tax position in the next 12 months.
CY2022 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In the normal course of business, the Company is subject to examination by tax authorities. As of the date of the financial statements, there are no tax examinations in progress. The statute of limitations for tax years ended December 31, 2019, December 31, 2018, and December 31, 2017 are open for federal, state, and foreign tax purposes, respectively.
CY2022 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1.00
CY2022 us-gaap Defined Benefit Plan Plan Assets Contributions By Plan Participant
DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
1000.00
CY2022 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.04
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
7500000
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3300000
CY2022 us-gaap Defined Contribution Plan Increase Decrease Cost
DefinedContributionPlanIncreaseDecreaseCost
800000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-29267000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
9840000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
13789000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52837674
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49815914
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32033827
CY2022 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
0
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
12490452
CY2022 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2020 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
191194
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52837674
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55594159
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51554996
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.55
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.55
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5168217

Files In Submission

Name View Source Status
nari-20221231_cal.xml Edgar Link unprocessable
nari-20221231_def.xml Edgar Link unprocessable
0000950170-23-004675-index-headers.html Edgar Link pending
0000950170-23-004675-index.html Edgar Link pending
0000950170-23-004675.txt Edgar Link pending
0000950170-23-004675-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img65717632_0.jpg Edgar Link pending
img65717632_1.jpg Edgar Link pending
img65717632_10.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
img65717632_11.jpg Edgar Link pending
img65717632_12.jpg Edgar Link pending
img65717632_13.jpg Edgar Link pending
img65717632_2.jpg Edgar Link pending
img65717632_3.jpg Edgar Link pending
img65717632_4.jpg Edgar Link pending
img65717632_5.jpg Edgar Link pending
img65717632_6.jpg Edgar Link pending
img65717632_7.jpg Edgar Link pending
img65717632_8.jpg Edgar Link pending
img65717632_9.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nari-20221231.htm Edgar Link pending
nari-20221231.xsd Edgar Link pending
nari-ex10_28.htm Edgar Link pending
nari-ex10_29.htm Edgar Link pending
nari-ex21_1.htm Edgar Link pending
nari-ex23_1.htm Edgar Link pending
nari-ex31_1.htm Edgar Link pending
nari-ex31_2.htm Edgar Link pending
nari-ex32_1.htm Edgar Link pending
nari-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
nari-20221231_pre.xml Edgar Link unprocessable
nari-20221231_lab.xml Edgar Link unprocessable
nari-20221231_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending